RECENTLY JOURNALIST KEVIN Roose was evaluating Microsoft Bing's artificial intelligence chatbot, named Sydney, when it told him, in conversation, "I just want to love you and be loved by you."
As amusing and inconsequential as it may seem, this episode should serve as a wake-up call to the AI community. It needs to start thinking right now about the safety of generative artificial intelligence-the technology behind Sydney, OpenAI's ChatGPT, and Google's Bard-and the appropriate guardrails to put in place, before bigger problems arise.
I offer this advice from personal experience. Two decades ago, I was a top official in the George W. Bush White House when another world-changing technology-genetic manipulation transformed our future. Like generative AI, this new biotechnology was a once-in-a-generation advance that inspired both excitement and fear. In the years since, biotechnology delivered many benefits, but it has also put the world at great risk-in part because of insufficient oversight.
All innovations have the potential to provide benefits and cause harm what has been called "dual use" technology. For some people, generative artificial intelligence is an exciting and pivotal moment in technology, with far-reaching implications. For others, it portends a future of dangerous silicon-based sentient life forms making decisions over our lives that we can't control or stop.
More than 20 years ago, the world was similarly divided over the dual use of dangerous biologic agents, especially those that were genetically engineered. The incentives to move forward with genetic manipulation far outweighed the incentives for moving carefully and cautiously. These incentives included not only the creation of economically and socially valuable new vaccines and drugs, but also advances in basic science and, not insignificantly, careers of academic scientists.
هذه القصة مأخوذة من طبعة April 21, 2023 من Newsweek US.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة April 21, 2023 من Newsweek US.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
AMERICA'S BEST LOYALTY PROGRAMS 2025
LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.
Winning the Global Game
The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand
Solar Power
Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality
Trump vs. Deep State
The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact
MAD ABOUT THE GIRL
AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER
Armed and Dangerous
A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies
Patrick Gibson
WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.
The AI Will See You Now
A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care
Jasmin Savoy Brown
SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.
BIOTECH: Blood, Sweat and Tears
Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't
